1-(3-氯-4-甲基苯基)乙酮 | 90792-98-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-(3-氯-4-甲基苯基)乙酮
• 中文别名: 3-氯-4-甲基苯乙酮
• 英文名称: 1-(3-chloro-4-methylphenyl)-ethanone
• 英文别名: 1-(3-chloro-4-methylphenyl)ethanone；3-chloro-4-methylacetophenone；1-(3-chloro-4-methyl-phenyl)-ethanone；1-(3-Chlor-4-methyl-phenyl)-aethanon；Methyl-(3-chlor-4-methyl-phenyl)-keton；3-Chlor-4-methyl-acetophenon
• CAS: 90792-98-6
• 化学式: C₉H₉ClO
• 分子量: 168.623
• InChiKey: PREFXQVOGOGFHD-UHFFFAOYSA-N

物化性质

• 熔点：
  44-45 °C
• 沸点：
  72-80 °C(Press: 1 Torr)
• 密度：
  1.130±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2914700090
• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  1-(3-氯-4-甲基苯基)乙酮 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 生成 (+/-)-2-Isopropylamino-1-<3-chlor-4-methyl-phenyl>-aethanol-(1)
  参考文献：
  名称：

  阻碍肾上腺素受体的一系列新物质。

  摘要：

  DOI：

  10.1021/jm00342a027
• 作为产物：
  描述：

  3-硝基-4-甲基苯乙酮 在 盐酸 、 溶剂黄146 、 tin(ll) chloride 作用下， 生成 1-(3-氯-4-甲基苯基)乙酮
  参考文献：
  名称：

  ANTIMALARIALS. α-PHENYL-β-DIALKYLAMINO ALCOHOLS¹

  摘要：

  DOI：

  10.1021/jo01169a001

文献信息

• Photoinduced Acetylation of Anilines under Aqueous and Catalyst-Free Conditions
  作者：Yu-Ming Yang、Wei Yan、Han-Wei Hu、Yimin Luo、Zhen-Yu Tang、Zhuangzhu Luo

  DOI：10.1021/acs.joc.1c01290

  日期：2021.9.3

  A green and efficient visible-light induced functionalization of anilines under mild conditions has been reported. Utilizing nontoxic, cost-effective, and water-soluble diacetyl as photosensitizer and acetylating reagent, and water as the solvent, a variety of anilines were converted into the corresponding aryl ketones, iodides, and bromides. With advantages of environmentally friendly conditions,

  已经报道了在温和条件下绿色且有效的可见光诱导的苯胺官能化。以无毒、经济、水溶性的双乙酰为光敏剂和乙酰化试剂，以水为溶剂，将多种苯胺转化为相应的芳基酮、碘化物和溴化物。该反应具有条件环境友好、操作简单、底物范围广、官能团耐受性好等优点，是一种有价值的有机合成方法。
• 8-Substituted isoquinoline derivative and the use thereof
  申请人：Kaneko Shunsuke

  公开号：US20100261701A1

  公开（公告）日：2010-10-14

  The present invention relates to a compound represented by the following formula (1): wherein D 1 , A 1 , D 2 , R 1 , D 3 , and R 2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.

  本发明涉及一种由以下式（1）表示的化合物： 其中D1，A1，D2，R1，D3和R2分别具有与本说明书中定义的相同含义或其盐。由式（1）表示的化合物或其盐具有IKKβ抑制活性等，对于预防和/或治疗IKKβ相关疾病或症状等方面是有用的。
• Triazine derivatives, a process for preparing the derivatives, and
  申请人：Idemitsu Kosan Company Limited

  公开号：US04680054A1

  公开（公告）日：1987-07-14

  A triazine derivative represented by the general formula: ##STR1## wherein R.sup.1 and R.sup.2 are each an alkyl group having 1 to 4 carbon atoms, and X.sup.1 and X.sup.2 are each a halogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxyl group having 1 to 4 carbon atoms, or an alkylthio group having 1 to 4 carbon atoms. This invention also provides a process for efficiently preparing said triazine derivative and a herbicide containing said triazine derivative as effective component.

  一种由以下通式表示的三嗪衍生物：##STR1## 其中R.sup.1和R.sup.2分别是具有1到4个碳原子的烷基基团，X.sup.1和X.sup.2分别是卤素原子、具有1到4个碳原子的烷基基团、具有1到4个碳原子的烷氧基基团或具有1到4个碳原子的烷基硫基团。本发明还提供了一种有效制备所述三嗪衍生物的方法和含有所述三嗪衍生物作为有效成分的除草剂。
• 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation
  申请人：Pharmacia Corporation

  公开号：US20020183362A1

  公开（公告）日：2002-12-05

  Methods of treating cyclooxygenase-2 mediated disorders comprising administering to a subject a therapeutically effective amount of one or more 2-fluorobenzenesulfonyl compounds corresponding to Formula I: 1 wherein A, R 1 , R 2 , and R 3 are as described in the specification, and novel 2 fluorobenzenesulfonyl compounds within Formula I.

  治疗环氧合酶-2介导的疾病的方法包括向受试者施用与公式I中对应的一种或多种2-氟苯磺酰化合物的治疗有效剂量：1其中A、R1、R2和R3如规范中所述，并且公式I内的新型2-氟苯磺酰化合物。
• ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
  申请人：Celgene Corporation

  公开号：US20200163948A1

  公开（公告）日：2020-05-28

  Compounds of formula I for treating, preventing or managing cancer are disclosed. Also disclosed are methods of treating, preventing or managing cancer, such as leukemia, comprising administering the compounds. In certain embodiments, the method of treatment comprise administering a compound provided herein in combination with a second agent. Pharmaceutical compositions and single unit dosage forms comprising the compounds are also disclosed.

  本文揭示了化学式I的化合物，用于治疗、预防或管理癌症。还揭示了治疗、预防或管理癌症的方法，例如治疗白血病，包括给予这些化合物。在某些实施例中，治疗方法包括与第二药物联合给药。此外，还揭示了包含这些化合物的药物组合物和单剂量形式。